Skip to main content

Table 1 Patient Demographic characteristics at baseline

From: Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial

Characteristics

 

A (n = 82)

B (n = 70)

C (n = 70)

p-value

Sex (Female), n

 

41

42

42

0.35

Age, y

35.16 ± 8.21

37.11 ± 6.56

34.41 ± 6.19

0.27

BMI (Kg/m2)

24.78 ± 8.34

24.76 ± 8.54

24.42 ± 7.70

0.17

Migraine type, n

Without Aura

51

39

44

0.62

With Aura

31

31

26

Headache history, y

5.23 ± 2.49

5.73 ± 2.14

4.89 ± 3.14

0.25

Family history of migraine, n

Yes

55

43

47

0.71

No

27

27

23